Stock Analysis

Here's What We Like About Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Upcoming Dividend

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) is about to trade ex-dividend in the next three days. The ex-dividend date generally occurs two days before the record date, which is the day on which shareholders need to be on the company's books in order to receive a dividend. It is important to be aware of the ex-dividend date because any trade on the stock needs to have been settled on or before the record date. This means that investors who purchase Fine Foods & Pharmaceuticals N.T.M's shares on or after the 28th of April will not receive the dividend, which will be paid on the 30th of April.

The company's next dividend payment will be €0.14 per share, on the back of last year when the company paid a total of €0.14 to shareholders. Based on the last year's worth of payments, Fine Foods & Pharmaceuticals N.T.M stock has a trailing yield of around 1.9% on the current share price of €7.26. If you buy this business for its dividend, you should have an idea of whether Fine Foods & Pharmaceuticals N.T.M's dividend is reliable and sustainable. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.

Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. Fine Foods & Pharmaceuticals N.T.M paid out a comfortable 44% of its profit last year. That said, even highly profitable companies sometimes might not generate enough cash to pay the dividend, which is why we should always check if the dividend is covered by cash flow. Thankfully its dividend payments took up just 26% of the free cash flow it generated, which is a comfortable payout ratio.

It's positive to see that Fine Foods & Pharmaceuticals N.T.M's dividend is covered by both profits and cash flow, since this is generally a sign that the dividend is sustainable, and a lower payout ratio usually suggests a greater margin of safety before the dividend gets cut.

See our latest analysis for Fine Foods & Pharmaceuticals N.T.M

Click here to see the company's payout ratio, plus analyst estimates of its future dividends.

historic-dividend
BIT:FF Historic Dividend April 24th 2025
Advertisement

Have Earnings And Dividends Been Growing?

Stocks with flat earnings can still be attractive dividend payers, but it is important to be more conservative with your approach and demand a greater margin for safety when it comes to dividend sustainability. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. That explains why we're not overly excited about Fine Foods & Pharmaceuticals N.T.M's flat earnings over the past five years. We'd take that over an earnings decline any day, but in the long run, the best dividend stocks all grow their earnings per share. Recent growth has not been impressive. However, companies that see their growth slow can often choose to pay out a greater percentage of earnings to shareholders, which could see the dividend continue to rise.

Many investors will assess a company's dividend performance by evaluating how much the dividend payments have changed over time. In the last six years, Fine Foods & Pharmaceuticals N.T.M has lifted its dividend by approximately 5.8% a year on average.

To Sum It Up

Is Fine Foods & Pharmaceuticals N.T.M worth buying for its dividend? The company has barely grown earnings per share over this time, but at least it's paying out a decently low percentage of its earnings and cashflow as dividends. This could suggest management is reinvesting in future growth opportunities. Generally we like to see both low payout ratios and strong earnings per share growth, but Fine Foods & Pharmaceuticals N.T.M is halfway there. It's a promising combination that should mark this company worthy of closer attention.

Ever wonder what the future holds for Fine Foods & Pharmaceuticals N.T.M? See what the two analysts we track are forecasting, with this visualisation of its historical and future estimated earnings and cash flow

A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About BIT:FF

Fine Foods & Pharmaceuticals N.T.M

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Solid track record with excellent balance sheet.

Advertisement

Weekly Picks

WE
WealthAP
PYPL logo
WealthAP on PayPal Holdings ·

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value:US$8229.7% undervalued
53 users have followed this narrative
4 users have commented on this narrative
29 users have liked this narrative
WO
BMBL logo
woodworthfund on Bumble ·

Swiped Left by Wall Street: The BMBL Rebound Trade

Fair Value:US$961.3% undervalued
17 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
WE
WealthAP
DUOL logo
WealthAP on Duolingo ·

Duolingo (DUOL): Why A 20% Drop Might Be The Entry Point We've Been Waiting For

Fair Value:US$268.6434.2% undervalued
32 users have followed this narrative
5 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

AN
andre_santos
SAP logo
andre_santos on SAP ·

SAP's Intrinsic and Historical Valuation

Fair Value:€162.7330.5% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DS
NKE logo
DS2invest on NIKE ·

Nike: A Market Leader with Resilience and Long-Term Growth Potential

Fair Value:US$43.0153.3% overvalued
15 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
GOOGL logo
yiannisz on Alphabet ·

The Real Power Behind Alphabet’s Growth

Fair Value:US$192.5470.7% overvalued
23 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.3% undervalued
70 users have followed this narrative
13 users have commented on this narrative
23 users have liked this narrative
AL
RKLB logo
AlexLovell on Rocket Lab ·

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25422.2% overvalued
73 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0226.9% undervalued
1029 users have followed this narrative
6 users have commented on this narrative
29 users have liked this narrative